XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 259,775 $ 102,891
Investments in marketable securities   14,857
Trade receivables, net 251,951 260,522
TSA receivables, net (Note 6) 32,194  
Inventory 61,978 62,605
Prepaid manufacturing 7,498 23,657
Other prepaids and current assets 14,081 11,099
Total current assets 627,477 475,631
Property and equipment, net 4,188 5,119
Inventory, non-current 65,645 67,495
Intangible assets, net 57,104 71,673
Other assets, non-current 9,131 9,686
Total assets 763,545 629,604
Current liabilities:    
Accounts payable 38,289 35,219
Accrued rebates, fees and reserves 155,775 169,645
TSA payables and other accrued liabilities (Note 6) 30,770  
Accrued compensation 22,762 21,521
Accrued and other current liabilities 115,707 105,386
Term loans, current 175,000  
Total current liabilities 538,303 331,771
Term loans, non-current 72,452 246,481
Convertible notes 227,220 226,888
Lease liabilities, non-current 4,680 5,328
Other liabilities, non-current 2,734 12,561
Total liabilities 845,389 823,029
Commitments and contingencies (Note 9)
Stockholders' deficit:    
Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 113,496,854 and 112,215,260 at March 31, 2024 and December 31, 2023, respectively) 11 11
Additional paid-in capital 1,395,042 1,386,312
Accumulated other comprehensive loss (272) (248)
Accumulated deficit (1,476,625) (1,579,500)
Total stockholders' deficit (81,844) (193,425)
Total liabilities and stockholders' deficit $ 763,545 $ 629,604